Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.
作者信息
Kiem Sungmin, Schentag Jerome J
机构信息
University at Buffalo School of Pharmaceutical Sciences and Pharmacy, Hochstetter Hall 445, Buffalo, NY 14260, USA.
出版信息
Antimicrob Agents Chemother. 2008 Jan;52(1):24-36. doi: 10.1128/AAC.00133-06. Epub 2007 Sep 10.
Abstract
摘要
相似文献
1
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.上皮衬液中抗生素浓度比值的解读
Antimicrob Agents Chemother. 2008 Jan;52(1):24-36. doi: 10.1128/AAC.00133-06. Epub 2007 Sep 10.
2
The penetration of dirithromycin into bronchoalveolar lavage fluid and alveolar macrophages.地红霉素在支气管肺泡灌洗液和肺泡巨噬细胞中的渗透情况。
J Antimicrob Chemother. 1994 May;33(5):1045-50. doi: 10.1093/jac/33.5.1045.
3
Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).酮内酯类药物泰利霉素（HMR 3647）的支气管肺分布情况。
Antimicrob Agents Chemother. 2001 Nov;45(11):3104-8. doi: 10.1128/AAC.45.11.3104-3108.2001.
4
Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.新合成的氟喹诺酮类抗菌药奥拉氟沙星经口给药后在大鼠肺上皮衬液和肺泡巨噬细胞中的分布特征
Eur J Pharm Biopharm. 2006 Oct;64(2):238-45. doi: 10.1016/j.ejpb.2006.04.009. Epub 2006 Jun 23.
5
Smoking-induced changes in epithelial lining fluid volume, cell density and protein.吸烟引起的上皮衬液体积、细胞密度和蛋白质的变化。
Eur Respir J. 1992 Jul;5(7):780-4.
6
Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.支气管肺泡灌洗显示培氟沙星在下呼吸道的蓄积。
J Antimicrob Chemother. 1994 May;33(5):979-85. doi: 10.1093/jac/33.5.979.
7
Tobramycin penetration into epithelial lining fluid of patients with pneumonia.妥布霉素在肺炎患者上皮衬液中的渗透情况。
Clin Pharmacol Ther. 1999 Mar;65(3):245-50. doi: 10.1016/S0009-9236(99)70103-7.
8
Microlavage: a technique for determining the volume of epithelial lining fluid.微量灌洗：一种用于测定上皮衬液体积的技术。
Thorax. 1991 Sep;46(9):658-62. doi: 10.1136/thx.46.9.658.
9
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.健康成年受试者血浆、上皮衬液和肺泡巨噬细胞中美罗培南-RPX7009的浓度。
Antimicrob Agents Chemother. 2015 Dec;59(12):7232-9. doi: 10.1128/AAC.01713-15. Epub 2015 Sep 8.
10
引用本文的文献
1
Development and validation of a LC-MS/MS method for the simultaneous determination of simnotrelvir and ritonavir in human serum and bronchoalveolar lavage fluid.用于同时测定人血清和支气管肺泡灌洗液中西莫瑞韦和利托那韦的液相色谱-串联质谱法的开发与验证。
BMC Chem. 2025 Jul 2;19(1):180. doi: 10.1186/s13065-025-01534-x.
2
Pharmacokinetics/pharmacodynamics of gamithromycin for treating Pasteurella multocida infection in cattle using a tissue cage model.使用组织笼模型研究加米霉素治疗牛多杀性巴氏杆菌感染的药代动力学/药效学
PLoS One. 2025 May 29;20(5):e0323727. doi: 10.1371/journal.pone.0323727. eCollection 2025.
3
Evaluating tigecycline dosing for hospital-acquired pneumonia patients: insights from physiologically-based pharmacokinetic modeling of lung exposure.评估替加环素对医院获得性肺炎患者的给药方案：基于肺暴露的生理药代动力学模型的见解
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0000425. doi: 10.1128/aac.00004-25. Epub 2025 May 20.
4
Determining an appropriate fosfomycin (ZTI-01) dosing regimen in pneumonia patients by utilizing minimal PBPK modeling and target attainment analysis.利用最小化生理药代动力学（PBPK）模型和达标分析确定肺炎患者合适的磷霉素（ZTI-01）给药方案。
Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0186924. doi: 10.1128/aac.01869-24. Epub 2025 May 5.
5
Biomarker-Driven Pharmacokinetics and Efficacy of Polymyxin B in Critically Ill Patients with XDR-GN Pneumonia.生物标志物驱动的多黏菌素B在XDR-GN肺炎重症患者中的药代动力学及疗效
Pharmaceuticals (Basel). 2025 Apr 17;18(4):586. doi: 10.3390/ph18040586.
6
Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteria.多药耐药革兰阴性菌所致肺炎患者雾化吸入与静脉注射多黏菌素B的群体药代动力学研究
Antimicrob Agents Chemother. 2025 May 7;69(5):e0004425. doi: 10.1128/aac.00044-25. Epub 2025 Apr 16.
7
Population Pharmacokinetics and Pharmacodynamics of Sitafloxacin in Plasma and Alveolar Epithelial Lining Fluid of Critically Ill Thai Patients With Pneumonia.泰国重症肺炎患者血浆和肺泡上皮衬液中司帕沙星的群体药代动力学和药效学
Pharmacol Res Perspect. 2025 Apr;13(2):e70081. doi: 10.1002/prp2.70081.
8
Translational Physiologically Based Pharmacokinetic Modeling to Predict Human Pulmonary Kinetics After Lung Delivery.基于生理学的药代动力学转化模型预测肺部给药后的人体肺部动力学
CPT Pharmacometrics Syst Pharmacol. 2025 Apr;14(4):796-806. doi: 10.1002/psp4.13316. Epub 2025 Mar 14.
9
Population pharmacokinetics and pulmonary modeling of eravacycline and the determination of microbiological breakpoint and cutoff of PK/PD.依拉环素的群体药代动力学与肺部建模以及微生物学折点和药代动力学/药效学临界值的确定
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0106524. doi: 10.1128/aac.01065-24. Epub 2025 Jan 29.
10
Online monitoring of propofol concentrations in exhaled breath.呼气中丙泊酚浓度的在线监测。
Heliyon. 2024 Oct 22;10(24):e39704. doi: 10.1016/j.heliyon.2024.e39704. eCollection 2024 Dec 30.
本文引用的文献
1
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.肺炎链球菌菌血症：与转归及大环内酯类耐药性的药效学相关性——一项对照研究
Int J Antimicrob Agents. 2007 Sep;30(3):264-9. doi: 10.1016/j.ijantimicag.2007.04.013. Epub 2007 Jun 22.
2
Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.加替沙星在健康年轻成人受试者和成年慢性支气管炎患者单次口服给药后的药代动力学，以及通过支气管镜微量采样和支气管肺泡灌洗获得的药物浓度比较。
Clin Ther. 2007 Jan;29(1):123-30. doi: 10.1016/j.clinthera.2007.01.005.
3
Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.单次和多次口服后使用支气管镜微量取样法测定泰利霉素的药代动力学
Pulm Pharmacol Ther. 2007;20(5):549-55. doi: 10.1016/j.pupt.2006.05.006. Epub 2006 Jun 12.
4
Pharmacokinetic considerations in the treatment of CNS tumours.中枢神经系统肿瘤治疗中的药代动力学考量
Clin Pharmacokinet. 2006;45(9):871-903. doi: 10.2165/00003088-200645090-00002.
5
Blood-neural barrier: intercellular communication at glio-vascular interface.血-神经屏障：神经胶质-血管界面处的细胞间通讯
J Biochem Mol Biol. 2006 Jul 31;39(4):339-45. doi: 10.5483/bmbrep.2006.39.4.339.
6
Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.健康志愿者中高剂量左氧氟沙星的肺内药代动力学和药效学
Int J Antimicrob Agents. 2006 Aug;28(2):114-21. doi: 10.1016/j.ijantimicag.2006.03.022. Epub 2006 Jul 11.
7
Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?将药物递送至中枢神经系统：是药物化学问题还是制药技术问题？
Curr Med Chem. 2006;13(15):1757-75. doi: 10.2174/092986706777452461.
8
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.药物代谢与药代动力学、血脑屏障及中枢神经系统药物发现
NeuroRx. 2005 Oct;2(4):554-71. doi: 10.1602/neurorx.2.4.554.
9
Drug delivery across the blood-brain barrier.药物透过血脑屏障的递送
Curr Drug Deliv. 2004 Oct;1(4):361-76. doi: 10.2174/1567201043334542.
10
Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.美罗培南的肺内药代动力学和药效学
Int J Antimicrob Agents. 2005 Dec;26(6):449-56. doi: 10.1016/j.ijantimicag.2005.08.015. Epub 2005 Nov 8.
Zotero 插件